GlassScriptPhysician profile
Susan Abbott
NPI 1972807972
$3,338.12
in general payments reported to CMS, 2019-2025
26 companies · $571 in 2025
The $571 reported for 2025 was more than what 89% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,024 · 2022: $306 · 2023: $1,071 · 2024: $366 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.52 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $808.04 | 2021-2025 | |
| Abbvie INC. | $789.70 | 2021-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $422.87 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $175.38 | 2021-2023 | Slynd |
| Evofem Biosciences, INC. | $174.67 | 2021-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $148.07 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $134.91 | 2021-2024 | Twirla |
| Aspira Women'S Health INC | $110.17 | 2023 | Ova1 |
| Sumitomo Pharma America, INC. | $99.69 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $97.09 | 2021-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Myovant Sciences INC. | $92.65 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $49.55 | 2021-2025 | Gardasil 9, Gardasil |
| Biogen, INC. | $29.76 | 2025 | Zurzuvae |
| Integra Lifesciences Corporation | $25.56 | 2025 | Tenoglide |
| Takeda Pharmaceuticals U.S.A., INC. | $25.53 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $19.56 | 2021 | |
| Scynexis, INC. | $18.88 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.74 | 2025 | |
| Optumhealth Care Solutions, LLC | $14.76 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Avion Pharmaceuticals | $12.43 | 2021 | |
| Dysis Medical, INC. | $12.22 | 2021 | |
| Therapeuticsmd, INC. | $12.02 | 2021 | |
| Trevena, INC. | $11.85 | 2021 | |
| Lupin INC. | $11.84 | 2021 | |
| Novo Nordisk INC | $11.69 | 2021 | |
| Millicent US INC | $11.49 | 2024 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Abbott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.